Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019009927) BLEND COMPOSITIONS FOR ORAL ADMINISTRATION AS A RAPIDLY DISSOLVING POWDER AND/OR SUSPENSION
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2019/009927 International Application No.: PCT/US2017/064281
Publication Date: 10.01.2019 International Filing Date: 01.12.2017
IPC:
A01N 43/04 (2006.01)
A HUMAN NECESSITIES
01
AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
N
PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
43
Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
02
having rings with one or more oxygen or sulfur atoms as the only ring hetero atom
04
with one hetero atom
Applicants:
ADORUS PHARMACEUTICALS LLC [US/US]; 4023 Kennett Pike Suite 810 Wllmington, DE 19807, US
Inventors:
FAVARA, Andrew; US
KARETNY, Marc; US
Agent:
BUCKLEY, Kevin, W.; US
Priority Data:
62/529,17006.07.2017US
Title (EN) BLEND COMPOSITIONS FOR ORAL ADMINISTRATION AS A RAPIDLY DISSOLVING POWDER AND/OR SUSPENSION
(FR) COMPOSITIONS DE MÉLANGE POUR ADMINISTRATION ORALE EN TANT QUE POUDRE ET/OU SUSPENSION À DISSOLUTION RAPIDE
Abstract:
(EN) Disclosed is a dry powder oral formulation that includes an active pharmaceutical ingredient (API), a lecithin powder, a galactomannan, one or more sweetening agents, one or more flavoring agents and an organic acid in a pharmaceutically acceptable preparation. Also disclosed are an excipient composition in absence of an API and methods of making and using the formulations and compositions. Also disclosed is a chewable, swallowable, and/or orally disintegrating tablet comprising an active pharmaceutical ingredient (API), a lecithin powder, a galactomannan, one or more sweetening agents, one or more flavoring agents and an organic acid in a pharmaceutically acceptable preparation.
(FR) L'invention concerne une formulation orale de poudre sèche qui comprend un principe pharmaceutique actif (API), une poudre de lécithine, un galactomannane, un ou plusieurs agents édulcorants, un ou plusieurs agents aromatisants et un acide organique dans une préparation pharmaceutiquement acceptable. L'invention concerne également une composition d'excipient en l'absence d'un API et des procédés de fabrication et d'utilisation des formulations et des compositions. L'invention concerne également un comprimé à mâcher, avaler et/ou déliter par voie orale comprenant un principe pharmaceutique actif (API), une poudre de lécithine, un galactomannane, un ou plusieurs agents édulcorants, un ou plusieurs agents aromatisants et un acide organique dans une préparation pharmaceutiquement acceptable.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)